Pretreatment with the gap junction uncoupler heptanol does not limit infarct size in rabbit heart

Citation
A. Gysembergh et al., Pretreatment with the gap junction uncoupler heptanol does not limit infarct size in rabbit heart, CARDIO PATH, 10(1), 2001, pp. 13-17
Citations number
17
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
CARDIOVASCULAR PATHOLOGY
ISSN journal
10548807 → ACNP
Volume
10
Issue
1
Year of publication
2001
Pages
13 - 17
Database
ISI
SICI code
1054-8807(200101/02)10:1<13:PWTGJU>2.0.ZU;2-D
Abstract
Previous findings indicate that heptanol, an agent well-recognized to disru pt chemical signaling between myocytes by uncoupling of gap junctions, sign ificantly limited infarct size when administered at the time of reperfusion . Our aim was to assess on the potential role of cell-cell communication vi a gap junctions during ischemia by investigating whether "loading" the soon -to-be ischemic territory with heptanol would limit myocardial necrosis. Fi ve isolated buffer-perfused rabbit hearts were pretreated with heptanol (0. 5 mM) for 10 min, while 12 served as controls. In the final 30 s of treatme nt, a large marginal branch of the left circumflex coronary artery was occl uded for 30 min followed by 2 h of reperfusion, and infarct size was deline ated by tetrazolium staining. Heptanol had no significant effect on the ext ent of infarct: area of necrosis (AN, expressed as a percentage of the myoc ardium at risk) was 75 +/- 3% and 72 +/- 8% in vehicle- and heptanol-treate d groups (P=.76). Thus, our results suggest that cell-to-cell communication via gap junctions during coronary artery occlusion does not contribute imp ortantly to the development of necrosis in rabbit heart. (C) 2001 Elsevier Science Inc. All rights reserved.